Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02981303
Brief Title: Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer

First Submitted : November 22, 2016
First Submitted that Met QC Criteria : November 30, 2016
First Posted : December 5, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 25, 2019
Last Update Posted : February 27, 2019